Philpot and Zylka receive R01 grant funding from the National Institute of Mental Health

National Institute of Mental Health (NIMH) grants Philpot and Zylka an R01 to study drugs that regulate expression of the protein Ube3a.

December 2011 - Faculty members Ben Philpot and Mark Zylka received a dual-PI R01 grant from the National Institute of Mental Health (NIMH) to study drugs that regulate expression of Ube3a, a ubiquitin protein ligase that is mutated in Angelman syndrome.